Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACIFIC: Comirnaty in Children with Acute Leukemia and Siblings
NCT04969601Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2021
- Primary completion
- Feb 2022
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of tozinameran in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2021; status: completed.
02
Drugs
tozinameran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04969601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04969601.